Beyond Biotech - the podcast from Labiotech
Welcome to the official Labiotech.eu podcast - Beyond Biotech! Each week, we talk about what's happening in the world of biotech, with news and interviews with experts from companies around the world. Join us as we cover the latest news, breakthroughs and innovations shaping the life sciences industry.A new podcast episode is available every Friday. The host is Dylan Kissane.
Podcasting since 2022 • 153 episodes
Beyond Biotech - the podcast from Labiotech
Latest Episodes
Humacyte: Saving lives with lab-grown blood vessels in conflict zones
Trauma surgeons in Ukraine operating theaters saved lives and limbs thanks to the innovative lab-grown blood vessels from US biotech, Humacyte.Humacyte is pioneering a platform that...
•
Episode 153
•
36:27
Special Episode: The 2025 BIO International Convention
Much of the attention of the biotech industry has been focused on the city of Boston this week as the annual BIO International Convention hit town. BIO is the world’s largest partnering conference for the biopharma industry a...
•
Episode 152
•
38:20
Alex Telford on AI, drug discovery, digital twins, and the most interesting questions in biotech
What are the most interesting questions in biotech, and is it even possible to find answers to those questions?Alex Telford is the co-founder of Convoke and a biotech blogger from the San Francisco Bay Area. His blog post, '
•
Episode 151
•
46:26
Corporate venture capital and biotechnology in 2025: challenges, opportunities, and threats
When biotechs start fundraising they regularly turn to the venture capital market seeking investment. The pool of VC money can be large, and part of that pool is corporate venture capital. Backed by firms keen to identify the next big thing in ...
•
Episode 150
•
42:12
The state of biotech finance and fundraising in Q2 2025 with Baker McKenzie
Biotechnology has always been a dynamic domain, but the world of finance that provides the fuel for the fire is just as vibrant. Trying to predict where the market for biotech investment is heading is always risky but for experts like Baker McK...
•
Episode 149
•
39:27